BusinessCascadian Therapeutics Announces Approval of Nonproprietary Name “tucatinib” for Lead Product Candidate ONT-380By Nasdaq OMXAug 31, 2016, 8:02 PM UTC
BusinessHemispherx Biopharma to Present Data on the Activity of Ampligen® Against Cancer at CHI’s 4th Annual Immuno-Oncology Summit, August 29 through September 2, 2016 in Boston, MABy Nasdaq OMXAug 29, 2016, 12:30 PM UTC
BusinessFate Therapeutics to Present at the Needham & Company 15th Annual Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 8:01 PM UTC
BusinessNemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 12:05 PM UTC
BusinessTESARO Announces Appointment of Dr. Kavita Patel to Board of DirectorsBy Nasdaq OMXApr 4, 2016, 12:00 PM UTC
BusinessKura Oncology Reports Fourth Quarter and Full Year 2015 Operational and Financial ResultsBy Nasdaq OMXMar 17, 2016, 8:05 PM UTC
BusinessTESARO Submits New Drug Application for Intravenous Rolapitant to the U.S. Food and Drug AdministrationBy Nasdaq OMXMar 14, 2016, 12:05 PM UTC
